Transcutaneous Monitors Market

Market Overview

The global transcutaneous monitors market size was valued at USD 175.69 million in 2023. It is estimated to reach USD 303.72 million by 2032, growing at a CAGR of 6.25 % during the forecast period (2024–2032), primarily driven by the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea.

Transcutaneous monitors are medical devices used to continuously measure certain physiological parameters through the skin, without the need for invasive procedures. These monitors typically use electrodes placed on the skin to measure parameters such as oxygen saturation (SpO2), carbon dioxide (CO2) levels, and sometimes, other gases like nitric oxide. The devices work by applying a small amount of heat to the skin, which causes blood vessels to dilate slightly, allowing for the measurement of gases that diffuse through the skin.

Technological advancements in these devices, including improved accuracy, portability, and ease of use, are also contributing to market growth. Additionally, the aging population worldwide is fueling the demand for continuous monitoring solutions, as elderly individuals are more prone to respiratory issues and other chronic conditions. Furthermore, the demand for non-invasive monitoring techniques is on the rise, as they offer reduced discomfort and risks compared to invasive methods. This trend is expected to further drive the adoption of transcutaneous monitors in various clinical settings, including neonatal intensive care units (NICUs) for monitoring premature infants.

Market Dynamics

Global Transcutaneous Monitors Market Drivers

Growing Demand for Non-Invasive Monitoring:

Transcutaneous monitors are particularly valuable in situations requiring frequent monitoring, such as during surgeries, in intensive care units, or for infants with respiratory issues. These monitors offer a non-invasive alternative to traditional methods, improving patient comfort and overall healthcare quality.

The proper use of transcutaneous monitors in neonatal care is essential for ensuring the best possible outcomes for premature infants. By adhering to guidelines such as those from the UK National Institute for Health and Care Excellence (NICE), healthcare providers can effectively monitor CO2 levels from initial stabilization to discharge, helping to identify and address any issues promptly.

Furthermore, the use of non-invasive ventilation methods to reduce lung damage in neonates is supported by the reduction in blood draws achieved through transcutaneous monitoring of CO2. This not only reduces pain and blood loss but also contributes to improved patient outcomes. As the trend towards non-invasive monitoring continues, it is expected to drive the development of more advanced transcutaneous monitoring technologies, thereby, expected to drive the market growth.

Growing Prevalence of Respiratory Diseases

The increasing incidence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea is driving the demand for continuous monitoring of respiratory parameters, including carbon dioxide levels. According to the World Health Organization, nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries (LMICs), highlights the global impact of these conditions and the need for accessible monitoring solutions. This demand is expected to boost the growth of the global transcutaneous monitoring market, as these devices offer non-invasive and continuous monitoring of carbon dioxide levels, particularly in critical care settings and for patients with respiratory conditions.

Global Transcutaneous Monitors Market Restraint

Limited Scope and Reliability

A key restraint for the global transcutaneous monitors market is the limited application of transcutaneous carbon dioxide (PtcCO2) measurement in certain clinical scenarios and patient populations. As per an article published by ScienceDirect, transcutaneous monitors has shown utility in critically ill neonates, however, its effectiveness in other settings, such as the operating room and ICU, and for unintubated children undergoing sedation, requires further validation through additional studies. The technology's reliance on skin preparation, sensor fixation, and calibration, along with concerns about its reliability in certain conditions, also pose significant challenges to its widespread adoption and use across different healthcare settings. Additionally, the lack of breath-to-breath monitoring capability for apnea and disordered breathing, is a clear disadvantage of the transcutaneous monitors.

Global Transcutaneous Monitors Market Opportunities

Integration with Telemedicine:

The integration of transcutaneous monitors with telemedicine presents significant opportunities in the global transcutaneous monitors market. This integration enables remote patient monitoring, allowing healthcare providers to track patients' vital signs such as oxygen saturation and carbon dioxide levels without the need for in-person visits. Real-time data transmission enhances communication between healthcare providers and patients, improving care coordination and enabling timely interventions. By eliminating geographical barriers to healthcare access, telemedicine with transcutaneous monitors improves patient access to care, particularly in remote or underserved areas. For instance, many telemonitoring devices are available with chronic respiratory diseases such as spirometers, forced oscillation technique devices, and continuous breathing monitors. They help track lung function and breathing patterns. In countries such as Japan, LTOT telemonitoring is covered by social insurance systems and is recognised as a new medical technology.

Overall, integrating transcutaneous monitors with telemedicine enhances patient engagement, scalability, and flexibility in respiratory monitoring, transforming the management of respiratory conditions.

Advancements in Sensor Technologies

Technological advancements have led to sensors that are more accurate, reliable, and comfortable for patients, expected to drive the adoption of transcutaneous monitors. For instance, BioIntelliSense's introduction of a pulse oximetry (SpO2) sensor chipset and integrated processing technology represents a significant technological advancement in the field of oximetry. This technology is capable of accurately measuring blood oxygen levels across a wide range of skin pigmentations and during movement and activity, addressing historical challenges in accuracy. Such advancements drive the adoption of pulse oximetry in diverse patient populations, improving healthcare equity and enabling the development of next-generation wearable devices for continuous monitoring.

These advancements will likely enhance the accuracy, reliability, and usability of transcutaneous monitors, expanding their applications across a wider range of clinical settings and contributing to the overall growth of the market.

Regional Analysis

Based on region, the global transcutaneous monitors market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America Dominates the Global Market

North America is the most significant global transcutaneous monitors market shareholder and is expected to expand substantially during the forecast period. North America stands as a prominent region in the global transcutaneous monitors market, characterized by well-established healthcare infrastructure, rise in preterm births, and strategic initiatives by key players.

The United States transcutaneous monitors market is leading in terms of market share as various manufacturers in the United States are adopting strategic initiatives such as collaborations, acquisitions, product launches, agreements, and research sponsorship to increase product sales. For instance, in December 2021, Royal Philips announced that its Philips Patient Monitors MX750 and MX850 received clearance from the United States Food and Drug Administration (FDA). These advanced monitors support scalability, alarm management, cybersecurity, and infection prevention, enhancing hospital monitoring capabilities.

Canada is expected to become a key player in the global transcutaneous monitors market due to the high prevalence of serious respiratory diseases. As per the Canadian Lung Association, over 6 million Canadians suffer from respiratory issues, with 2.28 million affected by asthma, one of the highest rates globally. This increases the demand for non-invasive monitoring devices that provide accurate and continuous data. Transcutaneous monitors offer a convenient and effective solution for managing respiratory conditions, aiding healthcare providers in better patient treatment and management.

Asia Pacific region is a pivotal market for the transcutaneous monitors industry, driven by the increasing adoption of new technologies, such as wireless connectivity and data analytics, in the region enhancing the functionality and usability of transcutaneous monitors, further driving market growth.

China transcutaneous monitors market has a major role in shaping the dynamics of the Asia-Pacific transcutaneous monitors market. As per BioMed Central Ltd, there are approximately 176 million OSA patients in China, with about 66 million classified as moderate to severe. Thus, the increasing prevalence of OSA in China, along with various demographic and lifestyle factors, is driving the demand for transcutaneous monitors for diagnosing and managing this sleep disorder

India is expected to emerge in transcutaneous monitors market. Key manufacturers such as Radiometer India offers the TCM4 monitor, providing non-invasive monitoring of oxygen (tcpO2), carbon dioxide (tcpCO2), and pulse oxygen saturation (SpO2) for patients in neonatal intensive care, intensive care units, and sleep diagnostics. These systems reduce the need for frequent blood draws, offering advanced monitoring solutions without the discomfort and risks of invasive sampling.

Thus, the factors above are estimated to boost the Asia-Pacific transcutaneous monitors market growth.

Segmental Analysis

The global transcutaneous monitors market is segmented by application and end-user.

Based on application, the global transcutaneous monitors market is divided into wound healing, neonatal & pediatric intensive care, blood gas monitoring, respiratory care, sleep diagnostics, and others.

The respiratory care segment dominates the global market. The respiratory care segment's dominance in the global market is underscored by the rising prevalence of respiratory diseases like COPD, asthma, and sleep apnea. These conditions necessitate ongoing monitoring of respiratory parameters, including carbon dioxide levels. Transcutaneous monitors excel in these scenarios due to their non-invasive and continuous monitoring capabilities, making them ideal for respiratory care settings.

For instance, Asthma continues to be a serious public health concern globally. According to the Asthma and Allergy Foundation of America, asthma stands as a prominent chronic disease among children, impacting around 4.5 million children below 18 years old.  As per the United States Environmental Protection Agency and the National Health Interview Surveys (NHIS) in April 2021, nearly 25.1 million people, including 5.1 million children, had asthma in the U.S. as of 2021. Similarly, the Indian Study on Epidemiology of Asthma, Respiratory Symptoms, and Chronic Bronchitis in Adults, published in April 2022, estimated the national burden of asthma at 17.23 million with an overall prevalence of 2.05% during 2021. Therefore, the rising cases of asthma across various countries are increasing the demand for critical role of respiratory care and the relevance of transcutaneous monitors in managing such prevalent conditions.

Based on the end-user, the global transcutaneous monitors market is bifurcated into hospitals, ambulatory surgical centers, neonatal intensive care units, and others. 

Hospital segment dominates the global transcutaneous monitors market. Hospitals are equipped with the necessary infrastructure and trained personnel to conduct intensive monitoring and critical care. Transcutaneous monitors are essential tools in intensive care units (ICUs) for both adult and pediatric patients, providing continuous and accurate monitoring of carbon dioxide levels, which is vital for patients with severe respiratory conditions or those undergoing major surgeries.

The demand for transcutaneous monitors is also driven by the need for neonatal care, particularly for preterm infants. For instance, according to detailed study reported in WHO, UNICEF, and the London School of Hygiene and Tropical Medicin an estimated 13.4 million babies, or about 1 in 10 live births, were born prematurely (before 37 weeks). Transcutaneous monitoring in neonates provides a real-time overview of fluctuating oxygenation (tcpO2) and ventilation (tcpCO2) status, which is critical for the care and management of preterm infants.

Thus, the increasing prevalence of respiratory conditions and the need for neonatal care in hospitals are key factors driving the significant share of hospitals in the transcutaneous monitors market.

Recent Developments

• November 2022- BioIntelliSense, Inc. launched its FDA-cleared pulse oximetry (SpO2) sensor chipset and integrated processing technology. This technology accurately measures blood oxygen levels across various skin pigmentation and during movement and activity.

Analyst’s Perspective:

As per our research analysts, the market for transcutaneous monitors is expected to grow steadily, driven by the increasing prevalence of chronic obstructive pulmonary disease (COPD) and asthma. The demand for non-invasive monitoring solutions and the growing trend towards the home healthcare are also contributing factors. Key market trends include the integration of wireless connectivity and data management capabilities, enabling remote monitoring and real-time data analysis. Manufacturers are focusing on developing user-friendly devices with advanced features to improve patient comfort and healthcare provider efficiency. Regulatory factors, such as compliance with standards and regulations for medical devices, play a crucial role in market growth. Companies investing in research and development to enhance product features and meet regulatory requirements are likely to gain a competitive edge.